Two separate pilot studies published in Nature Medicine have reported potential methods for improving arm and hand function in individuals who have experienced a stroke. One study examined spinal cord stimulation, while the other investigated a combined virtual reality and nerve stimulation platform.
Spinal Cord Stimulation for Chronic Stroke
Researchers at the University of Pittsburgh School of Medicine conducted a pilot clinical trial to assess cervical epidural spinal cord stimulation for improving arm and hand mobility in individuals with chronic stroke-related arm weakness. The final outcomes of this trial were published in Nature Medicine.
Study Details and Results
- Seven participants with chronic arm weakness due to stroke received the stimulation.
- The intervention was delivered over four weeks and involved fewer than nine hours of movement-based training.
- The study's primary aims were to evaluate safety and preliminary efficacy.
Measurements showed an average 32% increase in arm strength among participants.
- Overall arm mobility improved, and muscle spasticity decreased.
- No serious adverse events or discomfort were reported.
- All seven participants showed immediate improvement in strength when stimulation was active, regardless of the severity of their baseline impairment.
Mechanism and Context
The stimulation targets sensory nerve fibers in the spinal cord with targeted electrical signals. The stated goal is to enhance communication between the brain and weakened muscles. A similar class of device is already used for treating chronic pain; the study authors noted this was its first application for stroke-related arm impairment.
Follow-up Observations
Follow-up assessments indicated that motor function declined when the stimulation was discontinued. The study team has described the technology as functioning as an assistive neuroprosthetic rather than a permanent rehabilitation fix. The team has begun recruiting participants for an extended clinical trial to evaluate longer-term stimulation, both alone and in combination with physical therapy.
Participants and Funding
Participants varied in age, sex, and racial background. The study was supported by the NIH BRAIN Initiative, internal funding from the University of Pittsburgh, and the Department of Mechanical Engineering and Neuroscience Institute at Carnegie Mellon University. Senior author Marco Capogrosso, Ph.D., is an assistant professor of neurological surgery at Pitt. Co-author George Wittenberg, M.D., Ph.D., is a professor of neurology and physical medicine and rehabilitation at Pitt. Additional authors were affiliated with the University of Pittsburgh, Carnegie Mellon University, Columbia University, VA Pittsburgh Healthcare System, and Johns Hopkins University.
Background
Stroke is the leading cause of adult arm paralysis in the United States. Approximately 400,000 individuals develop chronic arm and hand weakness annually.
Virtual Reality and Nerve Stimulation Platform
A separate study published in Nature Medicine reported on a rehabilitation platform called MultiSensy, which combines virtual reality (VR) and electrical nerve stimulation.
Study Details and Results
- 34 stroke patients (at least three months post-stroke) participated.
- Participants were divided into two groups: one group received therapy using the MultiSensy platform, and the other group received conventional physiotherapy and occupational therapy.
- Both groups completed 12 sessions over three weeks.
The study reported that the group using the MultiSensy platform showed nearly twice the improvement on a standard motor impairment assessment compared to the control group.
- Patients using the platform also reported improvements in touch sensation and perception of their affected arm.
Platform Description
The MultiSensy platform uses VR goggles to present interactive tasks such as reaching, grasping, pinching, and forearm rotation. Electrodes placed on the skin stimulate sensory nerves in real time during these tasks. The system is designed to adapt tasks to each patient's impairment level and provides objective movement data for tracking progress.
Study Status and Limitations
The study was a small-scale clinical trial (n=34). The authors stated that larger trials are needed to confirm the benefits. The technology remains at a research stage but could potentially enable personalized, home-based rehabilitation in the future.